In Response to Arcidiacono et al.: "Should dose intensification be discontinued or should acceler- ated schemes remain an important area of clinical research?"
RADIOTHERAPY AND ONCOLOGY(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
RADIOTHERAPY AND ONCOLOGY(2023)